Lemminkäinen and YIT will complete the merger
LEMMINKÄINEN CORPORATION STOCK EXCHANGE RELEASE 9 APRIL 2014 AT 4:45 P.M RESOLUTIONS OF LEMMINKÄINEN CORPORATION'S ANNUAL GENERAL MEETING On 9 April 2014, Lemminkäinen Corporation's Annual General Meeting adopted the Company's annual accounts and consolidated financial statements for 2013 and granted the members of the Board of Directors and the President and CEO discharge from liability. Payment of dividend The General Meeting resolved, in accordance with the Board of Direc
LEMMINKÄINEN CORPORATION STOCK EXCHANGE RELEASE 9 APRIL 2014 AT 4:45 P.M
RESOLUTIONS OF LEMMINKÄINEN CORPORATION'S ANNUAL GENERAL MEETING
On 9 April 2014, Lemminkäinen Corporation's Annual General Meeting adopted the Company's annual accounts and consolidated financial statements for 2013 and granted the members of the Board of Directors and the President and CEO discharge from liability.
Payment of dividend
The General Meeting resolved, in accordance with the Board of Directors' proposal, that no dividend be paid for the financial year ended 31 December 2013.
Board membership and remuneration
The General Meeting confirmed the number of members of the Board of Directors as six. Berndt Brunow, Noora Forstén, Finn Johnsson, Juhani Mäkinen, Kristina Pentti-von Walzel, and Heikki Räty were elected as members of the Board.
The General Meeting confirmed that a remuneration of EUR 3,000 per month be paid to the members of the Board of Directors, EUR 10,000 per month be paid to the Chairman of the Board, and EUR 500 be paid in respect of each board meeting attended. It was further resolved that the Chairman of the Audit Committee be paid an attendance fee of EUR 1,000 and the members of the Audit Committee be paid an attendance fee of EUR 500 for each meeting of the Committee. In addition, it was resolved that the members residing abroad are to be paid the attendance fee increased by EUR 1,000. Travel expenses will be reimbursed as invoiced.
Election of the auditor and audit fee
PricewaterhouseCoopers Oy, a firm of authorised public accountants, was re-elected to serve as the Company's auditor. The audit fee will be paid as invoiced.
Authorisation to repurchase the Company's own shares
The General Meeting resolved, in accordance with the Board of Directors' proposal, to authorise the Board of Directors to resolve on the repurchase of the Company's own shares.
In accordance with the authorisation, the Board of Directors may resolve to repurchase a maximum of 1,000,000 own shares in one or several instalments, using the unrestricted shareholders' equity of the Company, subject to the provisions of the Finnish Companies Act on the maximum amount of own shares in the possession of the Company or its subsidiaries.
The Board of Directors may resolve to repurchase shares also in another proportion than in proportion to the holdings of shareholders. The shares shall be purchased in public trading at the prevailing market price. The purchases shall be carried out on NASDAQ OMX Helsinki Ltd. in accordance with its rules and regulations.
The authorisation is effective for a period of 18 months from the resolution of the General Meeting.
The previous authorisation granted to the Board of Directors regarding repurchase of own shares expired simultaneously.
Authorisation of the Board of Directors to resolve on a share issue and an issue of special rights
The General Meeting resolved, in accordance with the Board of Directors' proposal, to authorise the Board of Directors to resolve on a share issue and/or an issue of special rights entitling to shares referred to in Chapter 10, Section 1 of the Finnish Limited Liability Companies Act in one or several instalments, either against payment or without payment. The number of shares to be issued, including the shares to be received based on special rights, shall not exceed 3,900,000 shares. The maximum number corresponds to approximately 20 per cent of all the current shares of the Company. The Board of Directors may resolve to issue either new shares or own shares possibly held by the Company.
The authorisation entitles the Board of Directors to resolve on all terms and conditions of the share issue and the issue of special rights entitling to shares, including the right to derogate from the pre-emptive right of the shareholders. The authorisation may be used for the financing or execution of any acquisitions or other business arrangements, to strengthen the balance sheet and financial position of the Company or for other purposes as determined by the Board of Directors. The authorisation is in force for a period of 18 months from the resolution of the General Meeting. The previous authorisation, granted to the Board of Directors regarding a share issue and an issue of special rights expired simultaneously.
Minutes of the meeting
The minutes of the General Meeting of shareholders will be available on Lemminkäinen's website as from 23 April 2014 at the latest.
LEMMINKÄINEN CORPORATION
Corporate Communications
ADDITIONAL INFORMATION:
Senior Vice President, Legal Affairs
Johan Nybergh
tel. +358 2071 54811
johan.nybergh@lemminkainen.com
DISTRIBUTION:
NASDAQ OMX Helsinki
Key media
www.lemminkainen.com
Together with our customers we create conditions that make living, working and travelling functional, safe and healthy. We operate in northern Europe and employ about 7,800 experts. In 2013, our net sales were about EUR 2.2 billion. Lemminkäinen Corporation's share is quoted on NASDAQ OMX Nordic Exchange Helsinki. www.lemminkainen.com